EnGenome
Pre-clinicaleVai platform enables precise and early diagnosis of Rare Disease ensuring unprecedented accuracy in interpreting genomic variants.
Founded
2011
Focus
DiagnosticsGenetics & Genomics
About
eVai platform enables precise and early diagnosis of Rare Disease ensuring unprecedented accuracy in interpreting genomic variants.
Funding History
2Total raised: $6.5M
Series A$5MCDP Venture CapitalJun 15, 2023
Seed$1.5MCDP Venture CapitalSep 15, 2021
Company Info
TypePrivate
Founded2011
LocationPavia, Italy
StagePre-clinical
Contact
SIMILAR COMPANIES
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Pre-clinical · Milan
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile